Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Swigris

Concepts (372)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
67
2025
691
11.740
 Why?
Lung Diseases, Interstitial
62
2026
659
10.660
 Why?
Quality of Life
47
2025
3180
5.970
 Why?
Dyspnea
28
2025
250
5.750
 Why?
Pulmonary Fibrosis
26
2025
392
5.490
 Why?
Cough
10
2024
123
3.560
 Why?
Oxygen Inhalation Therapy
13
2021
180
3.320
 Why?
Surveys and Questionnaires
38
2025
6035
2.860
 Why?
Vital Capacity
33
2025
290
2.830
 Why?
Connective Tissue Diseases
13
2019
84
2.260
 Why?
Alveolitis, Extrinsic Allergic
6
2024
93
1.840
 Why?
Lymphangioleiomyomatosis
6
2024
36
1.720
 Why?
Arthritis, Rheumatoid
12
2024
1169
1.710
 Why?
Pyridones
12
2023
199
1.640
 Why?
Patient Reported Outcome Measures
7
2024
496
1.490
 Why?
Anti-Inflammatory Agents, Non-Steroidal
11
2021
338
1.480
 Why?
Patient Outcome Assessment
3
2021
132
1.390
 Why?
Severity of Illness Index
20
2025
2917
1.350
 Why?
Indoles
6
2024
500
1.340
 Why?
Sarcoidosis
5
2021
163
1.340
 Why?
Humans
166
2026
144298
1.270
 Why?
Aged
70
2025
25901
1.210
 Why?
Lung
21
2024
4084
1.210
 Why?
Pulmonary Medicine
3
2022
78
1.210
 Why?
Middle Aged
82
2025
35892
1.190
 Why?
Fatigue
9
2024
363
1.160
 Why?
Walking
7
2013
542
1.090
 Why?
Respiratory Function Tests
19
2025
541
1.080
 Why?
Oxygen
7
2023
978
0.990
 Why?
Psychometrics
10
2022
731
0.990
 Why?
Patients
3
2018
181
0.960
 Why?
Tomography, X-Ray Computed
20
2025
2741
0.950
 Why?
Hypertension, Pulmonary
6
2023
1946
0.940
 Why?
Male
91
2025
72263
0.930
 Why?
Exercise Test
9
2024
626
0.910
 Why?
Female
94
2025
78137
0.900
 Why?
Research Design
5
2016
1128
0.900
 Why?
Health Care Costs
3
2018
425
0.900
 Why?
Health Status Indicators
4
2014
166
0.900
 Why?
Patient-Centered Care
2
2021
540
0.860
 Why?
Activities of Daily Living
6
2022
441
0.850
 Why?
Disease Progression
20
2025
2844
0.840
 Why?
Reproducibility of Results
18
2024
3408
0.810
 Why?
Exercise Tolerance
4
2020
282
0.790
 Why?
Mycophenolic Acid
4
2016
120
0.740
 Why?
Forced Expiratory Volume
12
2023
448
0.720
 Why?
Idiopathic Interstitial Pneumonias
7
2026
44
0.690
 Why?
Organizational Objectives
1
2021
66
0.680
 Why?
Autoimmune Diseases
5
2026
462
0.670
 Why?
Internet
2
2016
698
0.670
 Why?
Nursing Research
1
2021
49
0.660
 Why?
Patient Satisfaction
3
2021
706
0.660
 Why?
Caregivers
4
2019
1051
0.650
 Why?
Pulmonary Emphysema
2
2024
275
0.630
 Why?
Lactic Acid
1
2022
301
0.630
 Why?
Rhinitis, Allergic
1
2020
42
0.600
 Why?
Chronic Disease
5
2022
1809
0.600
 Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.600
 Why?
Symptom Assessment
1
2020
136
0.600
 Why?
Pulmonary Disease, Chronic Obstructive
4
2022
919
0.580
 Why?
Fatty Acids
1
2022
447
0.560
 Why?
Emphysema
1
2018
100
0.530
 Why?
Patient Education as Topic
3
2019
771
0.500
 Why?
Particulate Matter
1
2020
336
0.500
 Why?
Needs Assessment
2
2019
401
0.500
 Why?
Longitudinal Studies
9
2020
2940
0.490
 Why?
Lung Diseases
3
2015
780
0.490
 Why?
Pulmonary Diffusing Capacity
7
2019
78
0.480
 Why?
Aged, 80 and over
19
2021
8265
0.480
 Why?
Heart Rate
2
2011
849
0.470
 Why?
Immunosuppressive Agents
4
2016
834
0.460
 Why?
Qualitative Research
4
2017
1660
0.460
 Why?
Lung Transplantation
1
2019
329
0.460
 Why?
Prognosis
16
2026
4293
0.450
 Why?
United States
25
2024
15979
0.450
 Why?
Information Seeking Behavior
1
2016
39
0.450
 Why?
Treatment Outcome
20
2023
11713
0.450
 Why?
Myositis
4
2025
57
0.450
 Why?
Air Pollutants
1
2020
429
0.440
 Why?
Gastroesophageal Reflux
2
2021
236
0.440
 Why?
Exercise
4
2022
2183
0.440
 Why?
Adult
39
2024
40408
0.440
 Why?
Narration
1
2016
73
0.440
 Why?
Double-Blind Method
10
2024
2032
0.430
 Why?
Ambulatory Care
2
2018
603
0.430
 Why?
Mental Health
2
2020
790
0.420
 Why?
Kaplan-Meier Estimate
8
2018
966
0.410
 Why?
Retrospective Studies
27
2025
17104
0.400
 Why?
Autoantibodies
6
2023
1504
0.400
 Why?
Autoimmunity
2
2019
928
0.400
 Why?
Telemedicine
1
2023
957
0.400
 Why?
Antibodies, Monoclonal
1
2021
1501
0.390
 Why?
Biomedical Research
2
2018
712
0.390
 Why?
Antitussive Agents
1
2013
7
0.390
 Why?
Bronchiolitis Obliterans
1
2013
61
0.380
 Why?
Thalidomide
1
2013
43
0.380
 Why?
Social Media
1
2016
167
0.380
 Why?
Lung Neoplasms
4
2024
2643
0.370
 Why?
Motivation
1
2017
601
0.370
 Why?
Social Support
2
2019
647
0.370
 Why?
Physicians
2
2019
948
0.370
 Why?
Survival Rate
7
2019
2081
0.360
 Why?
Bronchial Diseases
1
2012
38
0.360
 Why?
Patient Participation
1
2015
428
0.350
 Why?
Follow-Up Studies
9
2018
5404
0.340
 Why?
Quality Indicators, Health Care
1
2014
335
0.330
 Why?
Oxygen Consumption
3
2022
715
0.330
 Why?
Scleroderma, Systemic
4
2019
123
0.330
 Why?
Health Knowledge, Attitudes, Practice
2
2018
1405
0.320
 Why?
Multivariate Analysis
5
2017
1537
0.320
 Why?
Peptides, Cyclic
1
2012
275
0.320
 Why?
Health Status
5
2019
833
0.320
 Why?
Asthma
2
2020
1770
0.310
 Why?
Protein Kinase Inhibitors
3
2021
969
0.310
 Why?
Endothelins
1
2010
61
0.300
 Why?
Motor Activity
1
2014
723
0.300
 Why?
Hospitalization
3
2017
2440
0.300
 Why?
Cause of Death
6
2019
463
0.290
 Why?
Diagnosis, Differential
7
2019
1501
0.290
 Why?
Pulmonologists
2
2019
14
0.290
 Why?
Pulmonary Embolism
1
2011
241
0.280
 Why?
Cohort Studies
8
2025
5948
0.280
 Why?
Proportional Hazards Models
4
2019
1322
0.280
 Why?
TRPP Cation Channels
1
2009
74
0.280
 Why?
Amino Acyl-tRNA Synthetases
3
2016
32
0.280
 Why?
Endothelin-1
1
2010
181
0.280
 Why?
Polycystic Kidney Diseases
1
2009
71
0.270
 Why?
Randomized Controlled Trials as Topic
6
2021
1739
0.270
 Why?
Registries
4
2025
2389
0.270
 Why?
Sleep Apnea, Obstructive
1
2012
300
0.260
 Why?
Prospective Studies
9
2021
7972
0.260
 Why?
Sirolimus
2
2023
280
0.250
 Why?
Vascular Endothelial Growth Factor D
3
2023
13
0.250
 Why?
Bronchoalveolar Lavage Fluid
2
2025
628
0.250
 Why?
Biopsy
7
2016
1078
0.240
 Why?
Sex Distribution
3
2012
386
0.240
 Why?
Tumor Suppressor Proteins
1
2009
318
0.240
 Why?
Home Care Services
2
2020
280
0.240
 Why?
Exercise Therapy
3
2024
474
0.230
 Why?
Prevalence
5
2018
2836
0.230
 Why?
Mortality
4
2019
376
0.230
 Why?
Palliative Care
3
2019
1008
0.230
 Why?
Cost of Illness
3
2018
322
0.230
 Why?
Patient Advocacy
2
2024
71
0.230
 Why?
Lupus Erythematosus, Systemic
1
2008
237
0.220
 Why?
Quality Improvement
1
2014
1287
0.220
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
122
0.220
 Why?
Fibrosis
2
2024
547
0.210
 Why?
Minimal Clinically Important Difference
2
2021
31
0.200
 Why?
Thrombosis
1
2008
395
0.200
 Why?
Age Distribution
3
2019
402
0.200
 Why?
Time Factors
7
2019
7128
0.190
 Why?
Databases, Factual
3
2019
1489
0.190
 Why?
Evidence-Based Medicine
2
2020
732
0.190
 Why?
Delphi Technique
1
2024
329
0.180
 Why?
Respiratory Therapy
2
2019
25
0.180
 Why?
Sex Factors
6
2019
2103
0.180
 Why?
Environmental Exposure
2
2020
573
0.180
 Why?
Receptors, Lysophosphatidic Acid
1
2021
40
0.170
 Why?
Patient Care Management
1
2021
56
0.170
 Why?
Incidence
3
2018
2886
0.160
 Why?
Analysis of Variance
3
2015
1300
0.160
 Why?
Linear Models
3
2019
845
0.160
 Why?
Survival Analysis
3
2017
1368
0.160
 Why?
Pain Measurement
1
2022
553
0.160
 Why?
Interleukin-13
1
2021
144
0.160
 Why?
Logistic Models
4
2019
2112
0.150
 Why?
Antibodies, Antinuclear
4
2016
62
0.150
 Why?
Focus Groups
3
2016
566
0.150
 Why?
Walk Test
2
2017
80
0.150
 Why?
Risk Factors
8
2021
10783
0.150
 Why?
Sensitivity and Specificity
3
2015
1990
0.150
 Why?
Chi-Square Distribution
2
2011
524
0.140
 Why?
General Practitioners
1
2019
26
0.140
 Why?
Allied Health Personnel
1
2019
55
0.140
 Why?
Insurance Claim Review
1
2018
83
0.140
 Why?
Immunoglobulin A
1
2019
214
0.140
 Why?
Lipid Metabolism
1
2022
522
0.140
 Why?
Terminal Care
2
2019
282
0.140
 Why?
Oxidation-Reduction
1
2022
1073
0.130
 Why?
Accelerometry
2
2019
118
0.130
 Why?
Anxiety
3
2019
1114
0.130
 Why?
Attitude to Health
2
2014
431
0.130
 Why?
Physician Assistants
1
2019
101
0.130
 Why?
Weight-Bearing
1
2018
181
0.130
 Why?
Cellular Senescence
1
2019
223
0.130
 Why?
Allergens
1
2020
386
0.120
 Why?
Inflammation
2
2025
2862
0.120
 Why?
Cross-Sectional Studies
4
2019
5862
0.120
 Why?
Germany
1
2017
138
0.120
 Why?
Nurse Practitioners
1
2019
138
0.120
 Why?
Nurses
1
2019
167
0.120
 Why?
Common Variable Immunodeficiency
1
2016
25
0.120
 Why?
Host-Pathogen Interactions
1
2019
369
0.120
 Why?
Perception
1
2019
376
0.120
 Why?
Sulfonamides
2
2010
579
0.120
 Why?
Antihypertensive Agents
2
2010
512
0.120
 Why?
Granuloma
1
2016
96
0.120
 Why?
Tidal Volume
1
2016
111
0.120
 Why?
Cyclophosphamide
1
2016
265
0.120
 Why?
Medicare
2
2018
888
0.120
 Why?
Clinical Trials as Topic
3
2024
1055
0.110
 Why?
Muscle Strength
2
2015
330
0.110
 Why?
Health Policy
1
2018
398
0.110
 Why?
Physical Conditioning, Human
1
2015
38
0.110
 Why?
Nitric Oxide
1
2020
894
0.110
 Why?
Neuroendocrine Cells
1
2015
33
0.110
 Why?
Rituximab
1
2016
211
0.110
 Why?
Geographic Information Systems
1
2014
46
0.110
 Why?
Case-Control Studies
4
2019
3595
0.110
 Why?
Recovery of Function
1
2018
715
0.100
 Why?
Enzyme Inhibitors
2
2016
819
0.100
 Why?
Interviews as Topic
2
2016
904
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Societies, Medical
5
2020
890
0.100
 Why?
Sarcoidosis, Pulmonary
1
2015
97
0.100
 Why?
Sildenafil Citrate
1
2013
60
0.100
 Why?
Information Dissemination
1
2016
222
0.100
 Why?
Carbon Monoxide
3
2019
82
0.100
 Why?
Antifibrinolytic Agents
1
2014
61
0.100
 Why?
Sulfones
1
2013
126
0.100
 Why?
Phenotype
2
2018
3139
0.100
 Why?
Smoking
3
2019
1466
0.100
 Why?
Endpoint Determination
1
2013
84
0.100
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
42
0.100
 Why?
Predictive Value of Tests
3
2024
2113
0.090
 Why?
Purines
1
2013
187
0.090
 Why?
Practice Guidelines as Topic
1
2020
1565
0.090
 Why?
Patient Dropouts
1
2013
65
0.090
 Why?
Self Report
2
2019
867
0.090
 Why?
Antibiotics, Antineoplastic
1
2013
139
0.090
 Why?
Health Care Surveys
1
2014
537
0.090
 Why?
Pulmonary Gas Exchange
1
2012
116
0.090
 Why?
Histocompatibility Antigens Class II
1
2013
364
0.090
 Why?
Occupational Exposure
1
2016
353
0.090
 Why?
Adaptation, Psychological
1
2017
713
0.090
 Why?
Vasodilator Agents
1
2013
329
0.090
 Why?
Consensus
1
2013
475
0.090
 Why?
Delivery of Health Care
1
2018
942
0.090
 Why?
Minnesota
1
2012
168
0.090
 Why?
Dust
1
2012
101
0.090
 Why?
Piperazines
1
2013
378
0.080
 Why?
United Kingdom
1
2012
337
0.080
 Why?
Fear
1
2014
366
0.080
 Why?
Hydrogen-Ion Concentration
1
2012
559
0.080
 Why?
Clinical Competence
1
2019
1236
0.080
 Why?
Epidemiologic Methods
1
2010
89
0.080
 Why?
Young Adult
5
2017
14092
0.080
 Why?
Health Surveys
1
2012
516
0.080
 Why?
Anti-Infective Agents
1
2013
241
0.080
 Why?
Sickness Impact Profile
2
2009
62
0.080
 Why?
Salivary Glands, Minor
1
2009
10
0.070
 Why?
Pilot Projects
2
2015
1880
0.070
 Why?
Sjogren's Syndrome
1
2009
37
0.070
 Why?
Hyperplasia
2
2015
177
0.070
 Why?
International Cooperation
3
2015
197
0.070
 Why?
Risk
1
2011
910
0.070
 Why?
Scleroderma, Limited
1
2008
5
0.070
 Why?
Oximetry
1
2009
123
0.070
 Why?
Europe
3
2015
417
0.070
 Why?
Poisson Distribution
3
2016
78
0.070
 Why?
Radiography
2
2016
847
0.060
 Why?
Cardiac Catheterization
1
2011
554
0.060
 Why?
Wound Healing
1
2010
345
0.060
 Why?
Comorbidity
2
2017
1652
0.060
 Why?
Sleep Wake Disorders
1
2011
308
0.060
 Why?
Pericardium
1
2007
59
0.060
 Why?
Models, Statistical
1
2011
675
0.060
 Why?
Depression
2
2019
1557
0.060
 Why?
Clinical Trials, Phase III as Topic
2
2016
115
0.060
 Why?
Seasons
1
2008
555
0.060
 Why?
Medical Records
1
2006
190
0.060
 Why?
Regression Analysis
3
2016
997
0.060
 Why?
Singapore
1
2024
27
0.050
 Why?
California
1
2005
471
0.050
 Why?
Echocardiography
1
2007
644
0.050
 Why?
Bronchoscopy
1
2025
226
0.050
 Why?
Dose-Response Relationship, Drug
2
2020
2012
0.050
 Why?
Acute Disease
1
2006
1029
0.050
 Why?
Data Interpretation, Statistical
2
2018
368
0.050
 Why?
National Institutes of Health (U.S.)
1
2024
143
0.050
 Why?
ROC Curve
1
2025
615
0.050
 Why?
Terminology as Topic
1
2005
254
0.050
 Why?
Lymphoid Tissue
1
2002
78
0.050
 Why?
Rheumatologists
1
2022
15
0.050
 Why?
Exome
1
2023
227
0.040
 Why?
Whole Genome Sequencing
1
2023
183
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2021
76
0.040
 Why?
Age Factors
3
2019
3324
0.040
 Why?
Lysophospholipids
1
2021
78
0.040
 Why?
Patient Care
1
2022
118
0.040
 Why?
Telomere
1
2024
289
0.040
 Why?
Patient Selection
1
2005
721
0.040
 Why?
Attitude
1
2022
260
0.040
 Why?
Total Lung Capacity
1
2019
29
0.040
 Why?
Genomics
1
2025
828
0.040
 Why?
Occupations
1
2019
50
0.040
 Why?
Pulmonary Surfactant-Associated Protein A
1
2019
29
0.040
 Why?
Adolescent
3
2017
22370
0.040
 Why?
Pulmonary Surfactant-Associated Protein C
1
2019
45
0.040
 Why?
Disease Models, Animal
1
2010
4525
0.040
 Why?
GTPase-Activating Proteins
1
2019
81
0.040
 Why?
Blood Gas Analysis
1
2019
81
0.040
 Why?
Exoribonucleases
1
2019
45
0.040
 Why?
ATP-Binding Cassette Transporters
1
2019
118
0.040
 Why?
Administration, Inhalation
1
2020
569
0.030
 Why?
Education
1
2018
104
0.030
 Why?
DNA Helicases
1
2019
141
0.030
 Why?
Telomere-Binding Proteins
1
2019
119
0.030
 Why?
Administrative Claims, Healthcare
1
2017
28
0.030
 Why?
Watchful Waiting
1
2018
90
0.030
 Why?
Physical Endurance
1
2019
274
0.030
 Why?
Forecasting
1
2019
391
0.030
 Why?
Telomerase
1
2019
249
0.030
 Why?
Mucin-5B
1
2019
234
0.030
 Why?
Hypersplenism
1
2016
9
0.030
 Why?
Spirometry
1
2017
231
0.030
 Why?
Leukopenia
1
2016
33
0.030
 Why?
Banking, Personal
1
2016
2
0.030
 Why?
Sequence Analysis, DNA
1
2019
822
0.030
 Why?
Algorithms
1
2024
1839
0.030
 Why?
Rheumatoid Factor
1
2017
178
0.030
 Why?
Health Care Sector
1
2016
26
0.030
 Why?
Creatine Kinase
1
2016
72
0.030
 Why?
Death Certificates
1
2016
32
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
548
0.030
 Why?
Social Participation
1
2016
29
0.030
 Why?
Health Services Needs and Demand
1
2017
276
0.030
 Why?
Mass Screening
1
2024
1347
0.030
 Why?
Biomarkers
2
2019
4248
0.030
 Why?
Arthritis
1
2016
96
0.030
 Why?
Commerce
1
2016
79
0.030
 Why?
International Classification of Diseases
1
2016
147
0.030
 Why?
Multiple Pulmonary Nodules
1
2015
23
0.030
 Why?
Metals
1
2016
139
0.030
 Why?
Anthropometry
1
2015
197
0.030
 Why?
Promoter Regions, Genetic
1
2019
1244
0.030
 Why?
Physical Examination
1
2016
240
0.030
 Why?
Pandemics
1
2023
1693
0.030
 Why?
Genetic Variation
1
2019
982
0.030
 Why?
Disease-Free Survival
1
2016
768
0.030
 Why?
Alberta
1
2013
26
0.030
 Why?
Bronchiolitis
1
2015
87
0.030
 Why?
Mortality, Premature
1
2013
14
0.020
 Why?
Teaching
1
2016
237
0.020
 Why?
Adrenal Cortex Hormones
1
2016
479
0.020
 Why?
Odds Ratio
1
2016
1076
0.020
 Why?
Counseling
1
2016
405
0.020
 Why?
Drug Therapy, Combination
1
2016
1044
0.020
 Why?
RNA
1
2019
926
0.020
 Why?
Genome-Wide Association Study
1
2019
1373
0.020
 Why?
Congresses as Topic
1
2013
221
0.020
 Why?
Administration, Oral
1
2014
847
0.020
 Why?
Antigens, Human Platelet
1
2011
10
0.020
 Why?
Latin America
1
2011
95
0.020
 Why?
Japan
1
2011
145
0.020
 Why?
Genetic Predisposition to Disease
1
2019
2348
0.020
 Why?
Alanine-tRNA Ligase
1
2009
4
0.020
 Why?
Threonine-tRNA Ligase
1
2009
5
0.020
 Why?
Psychiatric Status Rating Scales
1
2011
539
0.020
 Why?
DNA Topoisomerases, Type I
1
2008
16
0.020
 Why?
Syndrome
1
2009
378
0.020
 Why?
Animals
1
2010
37800
0.020
 Why?
Cell Proliferation
1
2015
2485
0.020
 Why?
Lymphocytes
1
2009
379
0.020
 Why?
Pulmonary Wedge Pressure
1
2007
66
0.020
 Why?
Body Mass Index
1
2015
2417
0.020
 Why?
Risk Assessment
1
2015
3680
0.010
 Why?
Muscle, Skeletal
1
2015
1784
0.010
 Why?
Nuclear Proteins
1
2008
739
0.010
 Why?
Child
1
2002
22562
0.010
 Why?
Pneumonia
1
2008
627
0.010
 Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (372) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)